Clinical Pharmacology Study of CHF1535 pMDI 50/6 µg Versus The Free Combination In Asthmatic Children 5-11 Years Old

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2009
The rationale is to investigate the systemic availability of BDP/B17MP and formoterol after single oral inhalation of CHF 1535 50/6 pMDI vs the free combination of approved BDP and Formoterol pMDIs, in asthmatic children (5 to 11 years old).
Epistemonikos ID: 12ccd9a945578cac686f7aaee63e00561e81909b
First added on: May 11, 2024